Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Sanofi Japan Completes Merger of Genzyme Japan
July 4, 2016
- Eisai Gives Global R&D Updates on Dementia, Oncology
July 1, 2016
- Filing for 1st Japan-Made Nucleic Acid Expected by Year-End If PIII Yields Positive Data
July 1, 2016
- Toho Holdings Appoints Ex-Qol Exec Takada as Senior Executive Officer
July 1, 2016
- Nichi-Iko Aims for 20% Share of Generic Market in “80% Generic Era”: President
June 30, 2016
- Kyowa Kirin’s KRN23 Gets BT Designation for X-Linked Hypophosphatemia in Children
June 30, 2016
- Novel Anti-HIV Agent Genvoya to Hit Japan Market on July 8: JT, Torii
June 30, 2016
- Celgene Files Revlimid for ATL in Japan
June 30, 2016
- Reconsider Appropriate Diabetes Drug Combos Including GLP-1 Agents: Diabetologist
June 29, 2016
- MSD Initiates Long-Term Observational Study of Treatment with Oral Hypoglycemic Agents
June 29, 2016
- Boehringer-Sanofi Asset Swap Slated to Close by Year’s End; Fate of Japan Units Subject to Future Discussions
June 28, 2016
- Daiichi Sankyo, Servier Sign Sales Accord for Edoxaban in Canada
June 28, 2016
- Takeda Returns Japan Rights for Some Amgen Products
June 27, 2016
- Teijin Pharma Will Block Feburic Generic Erosions by Expanding Indications: President
June 24, 2016
- Cellular Dynamics, US National Eye Institute Ink Pact to Advance Cell Transplantation Therapy for AMD
June 24, 2016
- Univ. of Tokyo, Astellas to Codevelop Rice-Based Oral Cholera Vaccine
June 24, 2016
- Sanofi’s Antibody Drug for Atopic Dermatitis Close to Regulatory Filing
June 23, 2016
- Asahi Kasei Inks Collaboration with Finland’s Orion on Pain Therapies
June 23, 2016
- Interview: Bayer Yakuhin Chief Spearheading Initiatives to Trigger Behavior Change in Employees
June 23, 2016
- Fujifilm Inks 1st License Deal for Avigan Patents with Chinese Pharma
June 23, 2016
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…